Perosa F, Tsujisaki M, Ferrone S
J Immunol. 1987 Apr 1;138(7):2202-7.
BALB/c mice were immunized with syngeneic anti-HLA class I monoclonal antibodies. The latter included the anti-HLA-A2, A28 monoclonal antibody (MoAb) CR11-351, the MoAb Q6/64 to a determinant restricted to HLA-B antigens and the MoAb CR10-215 and CR11-115 to the same (or spatially close) monomorphic determinant. Anti-idiotypic antibodies could be detected in bleedings obtained 3 days after the first booster, increased in titer in bleedings obtained after the second booster, and persisted at high levels in subsequent bleedings. The four anti-HLA class I MoAb did not differ in their ability to elicit syngeneic anti-idiotypic antibodies. Cross-blocking studies with a panel of anti-HLA class I, anti-HLA class II, and anti-human melanoma-associated antigen (MAA) MoAb showed that the anti-MoAb CR10-215 and anti-MoAb CR11-115 antisera contain only antibodies to private idiotopes, whereas the anti-HLA MoAb CR11-351 and anti-MoAb Q6/64 antisera also contain antibodies to public idiotopes. The latter are expressed by the anti-HLA class I MoAb CR11-351, Q1/28, Q6/64, and 6/31, and by the anti-HLA class II MoAb Q5/6, Q5/13, 127, and 441. Public idiotopes were not detected on the nine anti-MAA MoAb tested. Public idiotopes do not interfere with the binding of anti-HLA MoAb with the corresponding antigenic determinants. On the other hand private idiotopes are located within the antigen-combining site, because anti-idiotypic antisera specifically inhibit the binding of the corresponding immunizing anti-HLA class I MoAb to cultured human lymphoid cells in a dose-dependent manner. Analysis by isoelectric focusing of the anti-HLA class I MoAb antisera showed that the spectrotype of the anti-MoAb CR11-351 antiserum comprises four components that focus in the pH 6.9 to 6.2 range, the spectrotype of anti-MoAb Q6/64 antiserum comprises three components that focus in the pH 6.5 to 6.1 range, the spectrotype of the anti-MoAb CR10-215 antiserum comprises three components that focus in the pH 6.4 to 6.1 range, and the spectrotype of the anti-MoAb CR11-115 antiserum comprises three components that focus in the pH 6.6 to 6.4 range.
用同基因抗HLA I类单克隆抗体免疫BALB/c小鼠。后者包括抗HLA - A2、A28单克隆抗体(MoAb)CR11 - 351,针对限于HLA - B抗原决定簇的MoAb Q6/64,以及针对相同(或空间上接近)单态决定簇的MoAb CR10 - 215和CR11 - 115。在首次加强免疫后3天获得的出血样本中可检测到抗独特型抗体,在第二次加强免疫后获得的出血样本中抗体滴度升高,并在随后的出血样本中持续保持高水平。这四种抗HLA I类MoAb在引发同基因抗独特型抗体的能力上没有差异。用一组抗HLA I类、抗HLA II类和抗人黑色素瘤相关抗原(MAA)MoAb进行的交叉阻断研究表明,抗MoAb CR10 - 215和抗MoAb CR11 - 115抗血清仅含有针对个体独特型的抗体,而抗HLA MoAb CR11 - 351和抗MoAb Q6/64抗血清还含有针对公共独特型的抗体。后者由抗HLA I类MoAb CR11 - 351、Q1/28、Q6/64和6/31以及抗HLA II类MoAb Q5/6、Q5/13、127和441表达。在所测试的9种抗MAA MoAb上未检测到公共独特型。公共独特型不干扰抗HLA MoAb与相应抗原决定簇的结合。另一方面,个体独特型位于抗原结合位点内,因为抗独特型抗血清以剂量依赖的方式特异性抑制相应的免疫抗HLA I类MoAb与培养的人淋巴细胞的结合。对抗HLA I类MoAb抗血清进行等电聚焦分析表明,抗MoAb CR11 - 351抗血清的光谱型包括聚焦在pH 6.9至6.2范围内的四个组分,抗MoAb Q6/64抗血清的光谱型包括聚焦在pH 6.5至6.1范围内的三个组分,抗MoAb CR10 - 215抗血清的光谱型包括聚焦在pH 6.4至6.1范围内的三个组分,抗MoAb CR11 - 115抗血清的光谱型包括聚焦在pH 6.6至6.4范围内的三个组分。